1 / 14

NGS Sample Preparation Market Size, Share, Growth, Sales Revenue and Key Driver

The Global NGS Sample Preparation Market is projected to reach USD 6.63 billion in 2027. Numerous advantages of high-performance sequencing compared to other genetic technologies, such as microarray and sanger-seq, are among the main driving forces in the Next Generation Sequencing (NGS) industry.

JD10
Download Presentation

NGS Sample Preparation Market Size, Share, Growth, Sales Revenue and Key Driver

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. www.emergenresearch.com NGS Sample Preparation Market Report 2019-2027 The increased advancements in NGS platforms, reduced price of sequencing, and improving the NGS-based diagnostic test reimbursement scenario are driving the demand for the market.

  2. Our Model Market Analysi Financia l Analysis s Distributi on Channel Analysis Brand Analysis www.emergenresearch.com Custom Market Intelligen ce Competito Product Analysis Custom Research r Analysis Demand Analysis Risk Analysis

  3. Business Plan Parameters End Use Analysis Demand Availability Analytics Market Entry Strategy Restructuring & Revival www.emergenresearch.com New Product Strategy Product Planning / Strategy SWOT Analysis Marketing / Distribution Channel Feasibility Customer Identification Survey Competitive Landscape / M&A Feasibility www.emergenresearch.com

  4. Industries We Cater to Power & Energy Food & Beverages Foods & Beverage, Food Ingredients, Food Processing and Equipment, Food Testing and Supply Chain, Health Food and Sports Nutrition, Frozen and Processed Food, Household, Retail Automotive Services Oil and Gas, Electricity, Energy Storage, Environmental, Renewable Energy www.emergenresearch.com Information and Tech Electric and Hybrid Vehicles, Off Highway and On Highway Vehicles, Aftermarket and Maintenance, Automotive Parts, Interior and Exterior Materials, Automotive electronics and Systems Data Security, Cloud Computing, IoT and Digitalization, Robotics, Telecom and Networking, Software and Services, Analytics, Semiconductor, Internet and E-Commerce Materials and Chemicals Pharma & Healthcare Medical Devices, Therapeutics, Biotechnology, Medical Imaging, Healthcare IT, Hospital Management, Diagnostics, Laboratory Equipment, Pharmaceutical Organic Chemicals, Disinfectants and Preservatives, Adhesives and Sealants, Polymers and Resins, Petrochemicals, Agrochemicals and Fertilizers, Paints and Coatings 5

  5. Market Summary The Global NGS Sample Preparation Market is projected to reach USD 6.63 billion in 2027. Numerous advantages of high-performance sequencing compared to other genetic technologies, such as microarray and sanger-seq, are among the main driving forces in the Next Generation Sequencing (NGS) industry. In addition, it is estimated that the availability of sampling techniques with low input DNA reduces overall costs is that, expanding the use of next-generation sequencing in various scientific and clinical applications. New England Biolabs technology that uses magnetic beads to mount the prototype will greatly enhance the procedures for sample preparation for the next generation. Recent advances in technology, for example, the Laboratory Information Management System (LIMS), for automation of genome libraries, often allow for next-generation sequencing at an affordable cost in a single day. The progress is expected to increase the number of next-generation users in the forecast period. This technology has drawn the interest of many companies and investors in various fields, including fundamental research, discovery, and production of pharmaceutical drugs, reproductive, and consumer genomics. In addition, the declining costs of next-generation data and their added value are expected to have a positive effect over traditional data, which contributes to lucrative revenue growth, on the diversification of this technology in other clinical fields. www.emergenresearch.com

  6. Market Summary Further key findings from the report suggest : For next-generation series, Oncology is calculated as the product with the largest income share on the market Genetic testing of the GNS will boost the health outcome dramatically, and the mortality rate so that acceptance of this segment is driven. Due to its numerous benefits across the entire genome market, the targeted sequencing sector dominated revenue shares in terms of coverage scope and multiplexing power. The segment would increase at a lucrative rate of growth due to substantial price reductions in the sequence of the whole genome. Furthermore, the key developers are dedicated to developing new, more powerful five-platforms. Over recent years, these factors have contributed to sales in the market. Request Free Sample : https://www.emergenresearch.com/request-sample/12 www.emergenresearch.com

  7. Market Summary Some Key HighlightsFrom the Report : Academic research companies are the largest end-users of income generation due to the high penetration in research activities of the seq-technology In January 2018, Illumina, Inc and KingMed Diagnostics agreed to build, with Illumina's next-generation sequencing (NOT) technology, groundbreaking oncology, and genetic disease research applications jointly. The collaboration represents a significant step towards the evaluation and approval of the Chinese Food and Drugs Authority (CFDA) and aims to provide patients across China with precision medicines. Major companies in the market report include : Agilent Technologies, Bio-Rad Laboratories, Inc., BGI; Biomatters Ltd., Congenica Ltd, Eurofins Scientific, DNASTAR, F. Hoffmann-La Roche Ltd, Genomatix GmbH, Thermo Fisher Scientific, and Foundation Medicine, among others. Request Free Sample Copy@ https://www.emergenresearch.com/request-sample/12 www.emergenresearch.com

  8. Market Summary For the purpose of this report, Emergen Research has segmented into the global NGS Sample Preparation Market on the basis of Workflow, Application, End-User, and region: Workflow Outlook (Revenue: USD Billion; Volume: Million Tons; 2017-2027) NGS Library Preparation Kits Semi-automated Library Preparation Automated Library Preparation Clonal Amplification Application Outlook (Revenue: USD Billion; Volume: Million Tons; 2017-2027) Oncology Clinical Investigation Reproductive Health HLA Typing/Immune System Monitoring Metagenomics, Epidemiology & Drug Development Agrigenomics & Forensics Consumer Genomics Read More @ https://www.emergenresearch.com/industry-report/ngs-sample-preparation-market

  9. Market Summary End-User Outlook (Revenue: USD Billion; Volume: Million Tons; 2017-2027) Academic Research Clinical Research Hospitals & Clinics Pharma & Biotech Entities Others Read More@ https://www.emergenresearch.com/industry-report/ngs-sample-preparation-market

  10. Parameter Details Market Size Estimation Period 2020-2028 Base Year Considered 2020 Historical Data 2017-2019 Forecast Period 2021-2028 Quantitative Units Revenue in USD million & CAGR from 2020 to 2028 Segments Covered Types, Application, End-Users, Regions & more. MARKET Countries Included The U.S., Germany, U.K., Italy, China, India, Japan, Brazil SEGMENTATION Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, and Trends Report Coverage Regions Scope North America, Europe, Asia Pacific, Latin America, Middle East and Africa Customization Scope 10 hours of free customization & expert consultation Explore Different Purchase Options & Request for Discount to Avail New Year Discount Pricing and Purchase Options www.emergenresearch.com

  11. Regional Share Dynamics www.emergenresearch.com

  12. LATEST PUBLICATIONS RELATED REPORTS: In-Vitro Diagnostics Market : https://www.emergenresearch.com/industry-report/in-vitro- diagnostics-market Diabetic Ketoacidosis Market : https://www.emergenresearch.com/industry-report/diabetic- ketoacidosis-market www.emergenresearch.com Wearable Organs Market : https://www.emergenresearch.com/industry-report/wearable-organs- market Hydroponics Market : https://www.emergenresearch.com/industry-report/hydroponics-market Pharmacogenomics Market : https://www.emergenresearch.com/industry- report/pharmacogenomics-market

  13. About Us At Emergen Research, we believe in advancing with technology. We are a growing market research and strategy consulting company knowledge base of cutting-edge market-disrupting technologies that are predicted to become more prevalent in the coming decade. with an exhaustive potentially and www.emergenresearch.com Our environment services optimal yield. Our analysts utilize their market proficiency to offer actionable help our clients implement profitable strategies and optimize their return services are wide-ranging, technological environment technological profiling existing opportunities capitalize on to stay ahead of your competitors expertise umbrellas all major you map the technological and actions to of industries, your our help ensure insights that on investment. right analysis highlights market Our from to the can that the in you

  14. Lets Talk; Contact Information Reach out to us and our Research Executives will ensure you get the report that meets all your requirements and address all your concerns. www.emergenresearch.com 14671 110 Avenue, Surrey, British Columbia, V3R2A9 www.emergenresearch.com sales@emergenresearch.com +1 (604) 757-9756

More Related